Cargando…
Repositioning of new potential schistosomicidal drugs using chemogenomic strategy
Autores principales: | Duarte, Arthur Scalzitti, Barreto Bezerra, José Clecildo, Almeida Silva, Lourival de, Neves, Bruno Junior, Andrade, Carolina, Vinaud, Marina Clare, Mello Silva, Clélia Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204113/ http://dx.doi.org/10.1186/1753-6561-8-S4-P55 |
Ejemplares similares
-
In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets
por: Calixto, Nicole Melo, et al.
Publicado: (2018) -
In Silico Search of Energy Metabolism Inhibitors for Alternative Leishmaniasis Treatments
por: Silva, Lourival A., et al.
Publicado: (2015) -
In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni
por: Neves, Bruno J., et al.
Publicado: (2015) -
Drug Repurposing for Paracoccidioidomycosis Through a Computational Chemogenomics Framework
por: de Oliveira, Amanda Alves, et al.
Publicado: (2019) -
Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2020)